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OBJECTIVES: To evaluate a self-regulation intervention
for asthma for older adults.
DESIGN: A blinded randomized controlled trial.
SETTING: Single-center tertiary care academic center.
PARTICIPANTS: Seventy older adults aged 65 and older
with persistent asthma randomized to an intervention or
control group.
INTERVENTION: Participants participate in a six-session
program conducted over the telephone and in group ses-
sions. Participants selected an asthma-specific goal, identi-
fied problems, and addressed potential barriers.
MEASUREMENTS: Outcomes were assessed at 1, 6, and
12 months and included the mini-Asthma Quality of Life
Questionnaire (mAQLQ), Asthma Control Questionnaire
(ACQ), healthcare utilization, exhaled nitric oxide
(FENO), and percentage of predicted forced expiratory
volume in 1 second (FEV1%).
RESULTS: The mAQLQ score was significantly higher in
the intervention group at 1, 6, and 12 months, even after
controlling for confounding factors. The between-group
difference decreased over time, although at 12 months, it
remained greater than 0.5 points. The ACQ was better in
the intervention group than in the control group at 1, 6,
and 12 months. At 12 months, those in the intervention
group were 4.2 times as likely as those in the control group
to have an ACQ score in the controlled range. Healthcare
utilization was lower in the intervention group, although
no difference was observed in FENO or predicted FEV1%.
CONCLUSION: A self-regulation intervention can
improve asthma control, quality of life, and healthcare utili-
zation in older adults. J Am Geriatr Soc 61:747–753, 2013.
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Asthma has frequently been overlooked in older adults.Physicians and patients often erroneously believe that
asthma is a disease that affects only children or that all
asthma begins in childhood, but studies show that up to
40% of adults with asthma have their first attack after the
age of 40.1,2 Underdiagnosis and delayed initiation of care
for asthma is common and can have dire consequences in
elderly adults.3–5 In the United States, the most recent data
shows that the asthma hospitalization rate for individuals
aged 65 and older is 237 per 100,000, which is the second
highest for any age group and only slightly less than the
rate for those younger than 15 (239 per 100,000).6 The
length of asthma hospitalizations was by far highest in per-
sons aged 65 and older, with an average of 4.5 days.
Although there have been more-dramatic decreases in
asthma mortality in younger individuals than in older
adults, the rates for older adults with asthma have only
recently plateaued.7,8 In the United States, individuals aged
65 and older have the highest asthma mortality of any age
group, accounting for more than 50% of all asthma
deaths.7,9,10 There are also significant concerns that
asthma mortality based on death certificate data underesti-
mate the true number of deaths in elderly adults, because
comorbidities may mask the true cause of death.11
Older adults with asthma have a disproportionate
level of morbidity and mortality related to the disease, but
little research has focused on optimal treatment and diag-
nostic strategies in this population,12 and many asthma
trials have excluded potential subjects aged 65 and
older.13–16 As the population of the United States ages, it
is expected that the number of older adults with asthma
will more than double, to nearly 5 million by 2,030.7
Therefore, novel approaches are necessary to improve the
care of this population.
A leading theory as to why asthma morbidity and
mortality have remained unacceptably high in older adults
is that the current diagnostic, therapeutic, and educational
approaches do not address the unique challenges this age
group faces.17 One approach to address these challenges
would be through an individualized self-regulation
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program. The self-regulation theory postulates that indi-
viduals must be invested in specific outcomes of personal
importance to enact meaningful behavioral change, regard-
less of how sound the medical advice may be.18 Through
the self-regulatory process, individuals are able to observe
and learn from their experience and determine methods
for changing behavior, improving multiple health out-
comes, but there have been few studies examining self-reg-
ulation as a method to improve health outcomes in elderly
adults, and its efficacy in this population is unclear.
The purpose of this study was to evaluate an asthma
self-regulation intervention for older adults, specifically
observing the effects on asthma quality of life (QoL) and
asthma control.
MATERIALS AND METHODS
Study Design
A randomized, double-blind, controlled trial was conducted
with patients from the University of Michigan Health Sys-
tem who met the study criteria. All patients provided writ-
ten informed consent for participation in the clinical trial.
The trial was registered at www.clinicaltrials.gov
(NCT00941694). Eligible participants were randomized in
a 1:1 ratio to the intervention and control groups using a
random number generator. After enrollment, all partici-
pants received standard asthma education administered by a
health educator. Topics included proper inhaler technique,
common asthma triggers, assessment of asthma control, and
signs of an asthma exacerbation. All participants were also
provided the American College of Chest Physicians Control-
ling Your Asthma patient education guide.19 An allergist
called participants randomized to the control group 1 and
2 weeks after enrollment to address any inquires regarding
information received during the asthma education session.
At enrollment, all participants completed a basic
health questionnaire, along with asthma-specific informa-
tion, spirometric evaluation, fraction of exhaled nitric
oxide level (FENO) (measured using the NIOX MINO,
Aerocrine Inc., New Providence, NJ), and allergy skin test-
ing for evaluation of atopy (using the Multi-Test II, Lin-
coln Diagnostics, Decatur, IL) to a battery of allergens,
including tree mix, weed mix, grass mix, mold mix, dog,
cat, dust mite, and cockroach. Asthma severity was based
upon daily controller medication use. Asthma severity of
participants who required an inhaled corticosteroid (ICS)
or leukotriene receptor antagonist (LTRA) as monotherapy
was considered mild, of those who required an ICS along
with one additional daily controller medication (LTRA,
long-acting beta agonist, theophylline, or anticholinergic
medication) was considered moderate, and of those requir-
ing daily oral corticosteroids or an ICS with two addi-
tional controller medications was considered severe.
Participants
Eligible participants were outpatients aged 65 and older
with a current physician diagnosis of asthma. All partici-
pants were currently using a daily controller medication
for asthma and had access to a home telephone. Partici-
pants were excluded if they had a diagnosis of chronic
obstructive pulmonary disease (COPD) or any other pri-
mary pulmonary disorder, were current smokers, had a
smoking history of longer than 20 pack-years (to exclude
individuals with likely COPD),20 or had mental impair-
ment that would preclude participation in an asthma self-
management program. All participants provided written
informed consent, and their primary care physicians
approved enrollment before randomization. Participants
and their physicians were blinded to group assignment.
The institutional review board at the University of
Michigan approved the study.
Intervention
After enrollment, participants randomized to the interven-
tion group were separated into cohorts of approximately
seven individuals and completed a 6-week asthma inter-
vention based on the social cognitive theory of behavioral
change. The intervention consisted of three in-person
group sessions and three one-on-one telephone sessions.
Group sessions included seven participants and a health
educator who served as the leader. A health educator who
had received a 2-day training session at the University of
Michigan Center for Managing Chronic Diseases on the
principles of self-regulation and the basics of asthma man-
agement conducted all group and telephone sessions.
The personalized intervention followed a self-regula-
tion process in which participants selected a specific
asthma-related problem they would like to address,
observed and researched their routine to see how asthma
was preventing resolution of this problem, and identified
and developed a plan to achieve this objective. Each step
of the intervention was self-directed, with personalized
assistance from the health educator. The final step of the
intervention focused on teaching participants how to man-
age asthma problems that might arise in the future.
A more-detailed description of the specific intervention ses-
sions can be found in the online supplemental repository,
along with common problems addressed (Table S1) and
barriers identified (Table S2). During the observation
phase, participants were provided with a peak flow meter
and asked to monitor peak flow readings along with
asthma symptoms over a 2-week period. The study team
did not recommend any specific medication changes.
Measures and Data Collection
Intervention and control subjects were grouped into
cohorts of approximately 14 individuals (7 intervention
and 7 control) for purposes of a matched follow-up sche-
dule. The baseline time point for both groups was 6 weeks
after enrollment in the study to allow the intervention
group to complete the self-regulation intervention. The pri-
mary outcome was asthma QoL as assessed according to
mini-Asthma Quality of Life Questionnaire (mAQLQ)
score assessed at 1, 6, and 12 months, after adjustment for
baseline AQLQ score, age, sex, body mass index (BMI),
asthma severity, presence of atopy (skin test reactivity to
any allergen), baseline percentage of predicted forced expi-
ratory volume in 1 second (FEV1%), and years of asthma.
The mAQLQ is a 15-item, 7-point scale addressing four
domains specific to individuals with asthma: activity limi-
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tations, symptoms, emotional function, and environmental
stimuli.21 It can be used to measure change over time and
has been commonly used in asthma studies. The minimally
clinically significant difference for AQLQ scores has been
defined as 0.5 points.22
Secondary outcomes included asthma control as mea-
sured using the Asthma Control Questionnaire (ACQ).23
The ACQ is a validated, 6-item questionnaire that assesses
daytime and nighttime asthma symptoms, rescue medica-
tion use, and the effect of asthma on daily functioning
over the previous 4 weeks. Scores range from 0 to 6, with
lower scores indicating better control. The ACQ can be
assessed as a continuous variable or dichotomized at 0.75,
which is the level that differentiates controlled from
uncontrolled asthma according to the National Institutes
of Health (NIH) National Asthma Education and Preven-
tion Program (NAEPP) guidelines.24 The ACQ was
assessed at 1, 6, and 12 months, after adjustment for base-
line ACQ, age, sex, BMI, asthma severity, presence of
atopy, baseline predicted FEV1%, and years of asthma.
Additional secondary outcome measures included
FENO, predicted FEV1%, oral corticosteroid courses, and
healthcare utilization (defined as emergency department
(ED), hospital, or unscheduled physician visits due to
asthma). A research assistant blinded to participant group
assignment performed all primary and secondary outcome
assessments.
Statistical Analysis
The primary endpoint of the study was the mAQLQ, a
standardized questionnaire with a maximum score of 7.0.
With a two-sided type I error rate of 0.05 and a within-
subject standard deviation of 0.9, as reported previously,25
study completion by 58 participants (29 participants per
arm) would provide 80% power to detect a difference
between groups of 0.75.
Univariate analyses were first performed using a t-test
to observe for differences between the groups for all out-
comes. Because of a nonlinear trend in mAQLQ and ACQ
scores, separate analyses were conducted at each outcome
time point. Using linear regression, associations between
mAQLQ (and domains) or ACQ scores and group assign-
ment were explored after controlling for each of the baseline
covariates (baseline mALQ or ACQ score, age, sex, race,
BMI, asthma severity, presence of atopy, baseline predicted
FEV1%, and years of asthma). The outcomes ACQ dichoto-
mized at 0.75, oral steroid courses, and healthcare utiliza-
tion were treated as dichotomous variables. For all
regression models, covariates that were significant at the
0.20 level during univariate analysis were modeled together.
Backward elimination with a cutoff value of 0.05 was used
to obtain the final model. All analyses were performed using
SAS version 9.2 (SAS Institute, Inc., Cary, NC).
RESULTS
Patients
One hundred eighty-one potential subjects were evaluated,
and 129 were deemed eligible for participation; 59 refused,
and 70 were ultimately enrolled. There were no significant
differences in age, race, or sex between those who refused
and those who were enrolled. Baseline characteristics of
study participants are summarized in Table 1. The groups
were similarly matched for all characteristics (P  .05 for
all comparisons), although there were more women in the
control group, and mAQLQ was slightly higher in the
intervention group. The control group had slightly greater
healthcare utilization than the intervention group, but this
was not statistically significant. Average BMI was high for
both groups, indicating that many participants were signif-
icantly overweight or obese. Figure 1 shows the number of
subjects completing each time point. At the end of the
1-year trial, 63 subjects (90%) were available for analysis.
Primary Endpoint: Asthma QoL
As shown in Figure 2, the mean mAQLQ score was signifi-
cantly higher in the intervention group than in the control
group at 1, 6, and 12 months. The magnitude of difference
between the two groups decreased over time, although even
at 12 months, the difference remained statistically signifi-
cant. To control for possible confounding effects (including
baseline mAQLQ score), a linear regression model was cal-
culated at each time point. As shown in Supplementary
Table S3, a statistically significant difference in mAQLQ
Table 1. Subject Characteristics
Clinical Characteristic
Intervention
Group, n = 34
Control Group,
n = 36
Age, mean  SD 72.8  5.6 73.8  6.9
Female, n (%) 23 (67.6) 31 (86.1)
Years with asthma, mean  SD 25.3  21.5 31.6  22.7
Caucasian, n (%) 27 (79.4) 29 (80.6)
Asthma severity, n (%)
Mild persistent 12 (35.3) 13 (36.1)
Moderate persistent 16 (47.1) 19 (52.8)
Severe persistent 7 (20.6) 4 (11.1)
Body mass index, kg/m2,
mean  SD
29.3  5.0 30.1  6.3
Atopy, n (%)a 27 (79.4) 27 (75.0)
Percentage of predicted forced
expiratory volume in 1 second,
mean  SD
84.2  27.4 80.9  23.6
Fraction of exhaled nitric oxide,
mean  SD
31.7  28.1 30.2  24.2
Mini-Asthma Quality of Life
questionnaire, mean  SD
5.82  0.92 5.52  0.94
Asthma Control Questionnaire,
mean  SD
1.14  0.74 1.29  0.90
Hospitalizations in prior 6
months, n (%)
3 (8.8) 4 (11.1)
Emergency department visits
in prior 6 months, n (%)
1 (2.9) 2 (5.6)
Unscheduled visits in prior 6
months, n (%)
6 (17.6) 13 (36.1)
No significant differences were noted between intervention and control
groups for any variable.
Hospitalizations, emergency department visits, and unscheduled visits indi-
cate the number of subjects in each group who had required this service
for asthma in the prior 6 months.
a≥1 positive skin tests.
SD = standard deviation.
JAGS MAY 2013–VOL. 61, NO. 5 SELF-REGULATION FOR OLDER ADULTS WITH ASTHMA 749
score between the groups was present at 1 and 6 months,
although this significance was lost at 12 months.
Secondary Endpoint: Asthma Control
Mean ACQ score was significantly lower (indicating better
control) at 1 month in the intervention group than in the
control group and was lower at the 6- (P = .06) and
12-month (P = .07) time points as well. As with the
mAQLQ, the magnitude of difference between the two groups
decreased over time (Figure 3). The ACQ was dichotomized
at 0.75 to assess asthma control further. At 1 month, inter-
vention group participants were 3.8 times as likely to have
an ACQ score less than 0.75 as those control group partici-
pants (95% confidence interval (CI) = 1.15–12.5, P = .03).
A significant difference was not observed at 6 months, but
at 12 months, intervention group participants were 4.2
times as likely to have an ACQ score less than 0.75 as those
control group participants (95% CI = 1.14–15.1, P = .03).
To control for possible confounding effects (including
baseline ACQ score), a linear regression model was calcu-
lated at each time point. As shown in Table S3, ACQ
score was significantly lower at 1 and 6 months, although
this significance was lost at 12 months.
Additional Secondary Endpoints
The specific AQLQ domain scores of the intervention and
control groups at 1, 6, and 12 months were compared. As
shown in Table 2, the greatest difference was observed in the
activity domain (significantly higher at all three time points),
although others such as the symptom and environmental
domains were statistically significantly different as well.
Lung function parameters (predicted FEV1% and
FENO) were evaluated at 6 and 12 months. No difference
was seen in FENO, but predicted FEV1% favored the
intervention group at 6 and 12 months (P = .09). Health-
care utilization statistics were evaluated at 6 and
12 months. There was no statistically significant difference
in hospitalizations or ED visits between the intervention
and control groups, although both favored the intervention
group. At 6 months, the number of subjects who had
required an unscheduled visit for asthma were lower in the
intervention group; at 12 months, unscheduled visits and
hospitalizations were lower in the intervention group.
When a composite healthcare utilization index (hospital-
ization, ED visit, or unscheduled visit) was calculated, the
intervention group had significantly fewer visits than the
control group at 6 and 12 months (P  .01 for both). At
12 months, the absolute risk reduction was 32% for
healthcare utilization, and the number needed to treat to
prevent one additional event was 3.1. Regression models
that included baseline healthcare utilization information
were calculated. As shown in Table S3, unscheduled visits
and overall healthcare utilization continued to remain sig-
nificant at the 6- but not the 12-month visit.
DISCUSSION
This preliminary study demonstrates that a self-regulation
intervention is effective for improving asthma QoL,
Screened -181
Eligible patients - 129
Declined - 59 Enrolled - 70
1-month - 33 (97%)
6-month - 33 (97%)
Intervention - 34 Control - 36
1-month - 31 (86%)
6-month - 32 (89%)
12-month  - 31 (91%) 12-month - 32 (89%)
Figure 1. Subject flow diagram.
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Figure 2. Mini-Asthma Quality of Life scores at 1, 6, and
12 months. Higher scores indicate greater quality of life.
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Figure 3. Asthma Control Questionnaire scores at 1, 6, and
12 months. Lower scores indicate greater asthma control.
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asthma control, and healthcare utilization in older adults.
Those who participated in the intervention were approxi-
mately four times as likely to achieve asthma control as
control subjects, and this effect persisted 1 year after the
intervention. Participants in the intervention group were
also able to decrease healthcare utilization, particularly
unscheduled office visits for asthma.
Older adults with asthma may have different symptoms,
spirometric findings, and response to therapy than younger
individuals. Research has found that older adults have spe-
cific concerns related to comorbidities, polypharmacy, and
spousal care that are often not addressed in traditional
asthma education and are often not discussed with their
physicians.26 This self-regulation intervention uses the
phases of self-observation, self-judgment, and self-reaction
and allows individuals to identify specific problems, barri-
ers, and goals to increase self-efficacy and eventually
improve multiple asthma outcomes. Self-regulation inter-
ventions have improved outcomes for older adults with
heart disease27 and medication noncompliance,28 and the
current study supports its efficacy in asthma.
Individuals with a chronic illness often chose QoL as
the one variable they would most like to improve, rather
than factors such as biomarkers, healthcare utilization,
and even longevity.29 This has also been found in individu-
als with asthma and is particularly true in elderly
adults.30,31 The intervention successfully improved QoL,
and even at 12 months, the difference between the control
and intervention groups was greater than the minimally
clinically significant difference of 0.5, although because the
difference between the groups decreased over time, a boos-
ter telephone call might be required for maximal pro-
longed benefit. Mood disorders can impair asthma QoL,32
and self-regulation interventions can improve depression.33
It is therefore possible that the improvement in QoL was
due to improved mood for individuals with depression,
and this deserves further evaluation.
Although the intervention did not directly target the
asthma control items contained in the ACQ, the interven-
tion group had significantly greater improvement than the
control group. A benefit of the self-regulation intervention
is that participants understand that control of items that
physicians typically consider important (e.g., symptom
identification, rescue inhaler use) allows participation in
activities that the patient deems important (e.g., walking
with grandchildren).
There were significantly fewer hospitalizations and
unscheduled visits but not ED visits at 12 months in the
intervention group. Although the overall numbers for
healthcare utilization were low, and this study was not
designed or powered for this endpoint, the results are
encouraging. A number needed to treat of slightly greater
than three indicates that this intervention has the potential
to decrease the disparities in asthma health care seen in
older adults.
Participants received the format of the intervention
particularly well. They noted that the camaraderie of the
group sessions, along with the personal attention of the
telephone calls, was a desirable mix. They were able to
share their asthma experiences, frustrations, and treatment
strategies with one another, thereby identifying the com-
monality and differences of their situation. Because older
adults may have limited social interaction opportunities, a
group format design may be particularly appealing to this
population.
Other studies have examined interventions to improve
asthma in elderly adults. One did not find that the addi-
tion of a peak flow meter improved asthma care in adults
aged 50 and older.34 The intervention in the current study
used peak flow meters, and perhaps the participants found
peak flow monitoring more effective through exploration
of the device’s ability to improve self-efficacy. Another
study found that exercise training was able to improve
QoL in older adults with asthma, although the magnitude
of change was not as great as in the current study, and the
follow-up period was only 3 months.35 Exercise can
improve self-efficacy in older adults,36 which could explain
some of the results seen in that study.
There are limitations to this study. This was a single-
center study, and the population was primarily overweight or
obese Caucasian women. Reversibility testing with a bron-
chodilator was not performed, although the latest NIH NAE-
PP guidelines specifically state that “chronic asthma may be
Table 2. Secondary Outcomes
Outcome Measure
Intervention
Group, n = 34
Control Group,
n = 36 P-Value
Asthma Quality of Life questionnaire score, mean
Symptoms
1 month 5.935 4.961 .001
6 months 5.794 5.269 .07
12 months 5.592 5.356 .37
Emotional
1 month 6.086 5.688 .27
6 months 6.091 5.813 .38
12 months 6.011 5.427 .07
Activity
1 month 6.283 5.202 .002
6 months 6.265 5.516 .02
12 months 6.097 5.352 .04
Environmental
1 month 5.768 4.237 .001
6 months 5.303 4.615 .11
12 months 5.204 4.635 .18
Asthma Control Questionnaire score <0.75, n (%)
1 month 16 (48.5) 7 (22.6) .03
6 months 18 (54.5) 12 (38.7) .21
12 months 13 (41.9) 5 (15.6) .02
Fraction of exhaled nitric oxide, mean
6 months 27.9 24.0 .50
12 months 25.9 26.6 .90
Percentage of predicted forced expiratory volume in 1 second, mean
6 months 87.4 81.1 .33
12 months 84.6 76.3 .17
Emergency department visits, n (%)
6 months 1 (3.0) 2 (6.2) .54
12 months 1 (3.2) 2 (6.2) .58
Hospitalizations, n (%)
6 months 0 (0.0) 3 (9.4) .07
12 months 0 (0.0) 4 (12.5) .04
Unscheduled visits, n (%)
6 months 5 (15.1) 12 (37.5) .04
12 months 6 (19.3) 14 (42.4) .048
Healthcare utilization, n (%)
6 months 5 (15.1) 14 (43.7) .01
12 months 6 (19.3) 17 (51.5) .008
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associated with a loss of response to bronchodilators,”24
which is especially true in individuals with longstanding
asthma, such as elderly adults.37 Mental impairment, a fre-
quent comorbidity in elderly adults, would preclude one’s
ability to participate in the program. The ability to incorpo-
rate a health educator may not be possible for all health sys-
tems, and a cost-benefit analysis was not performed. The
control group had higher baseline healthcare utilization, and
even though the regression analysis accounted for this dis-
crepancy, unmeasured variables may have introduced bias to
the study. The intervention group received more contacts
than the control group, and nonspecific interaction rather
than the content may have improved outcomes.
In conclusion, a self-regulation intervention can address
the unique challenges that older adults with asthma face. By
targeting a disease from an individual’s perspective rather
than illness from a physician’s perspective, this intervention
is ideally suited to improve outcomes in elderly adults. Par-
ticipation in the program was effective in improving asthma
QoL and control, although the benefit was partially lost at
1 year. Further exploration is required to decrease dispari-
ties in asthma health care seen in elderly adults.
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